The oxidative modification hypothesis of atherosclerosis: The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma

被引:135
作者
Nakajima, K
Nakano, T
Tanaka, A
机构
[1] Japan Immunores Labs Co Ltd, Takasaki, Gumma 3700021, Japan
[2] Tokyo Med & Dent Univ, Dept Geriatr Med, Tokyo, Japan
[3] Kanto Gakuin Univ, Coll Human & Environm Studies, Dept Hlth & Nutr, Yokohama, Kanagawa, Japan
关键词
oxidative modification; oxidized LDL (Ox-LDL); remnant lipoproteins; remnant-like lipoprotein particle-cholesterol (RLP-C); oxidized phospholipids; endothelial dysfunction; scavenger receptor; lectin-like oxidized LDL receptor-1 (LOX-1); endothelium-dependent vasorelaxation (EDR); flow-mediated vasodilation (FMD); hypercholesterolemia; metabolic syndrome; probucol; cilostazol; antioxidants;
D O I
10.1016/j.cca.2005.12.013
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A tremendous number of articles on oxidized LDL (Ox-LDL) and scavenger receptor in macrophage have been published since Steinberg proposed Ox-LDL hypothesis as the major cause of atherosclerosis. This hypothesis has provided strong support for the efficacy of LDL lowering drugs, indicating that lowering LDL means lowering Ox-LDL in vivo. This manuscript proposed a new oxidative modification hypothesis that remnant lipoproteins determined as remnant-like lipoprotein particles (RLP), not LDL are the major oxidized lipoproteins in plasma, resulting from the plasma concentration of these oxidized lipoproteins. Remnant lipoproteins may play a pivotal role for the initiation of atherosclerosis via lectin-like oxidized LDL receptor-1 (LOX-1) in endothelial cells. Isolated remnant lipoproteins were found to be oxidized or susceptible to be oxidized in plasma, not necessary to be further oxidized in vitro as Ox-LDL. High similarity of proatherogenic and proinflammatory properties of isolated Ox-LDL and remnant lipoproteins have been reported and predicted the presence of similar oxidized phospholipids in both lipoproteins as bioactive components. These results suggest the possibility that reducing plasma remnant lipoproteins rather than LDL should be the target for hyperlipidemic therapy especially in patients with metabolic syndrome for the prevention of endothelial dysfunction in the initiation of atherosclerosis. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 47
页数:12
相关论文
共 143 条
  • [1] Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans
    Anderson, TJ
    Meredith, IT
    Charbonneau, F
    Yeung, AC
    Frei, B
    Selwyn, AP
    Ganz, P
    [J]. CIRCULATION, 1996, 93 (09) : 1647 - 1650
  • [2] Ando M, 1999, J AM SOC NEPHROL, V10, P2177
  • [3] [Anonymous], 1991, OXIDATIVE STRESS OXI
  • [4] Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study
    Austin, MA
    McKnight, B
    Edwards, KL
    Bradley, CM
    McNeely, MJ
    Psaty, BM
    Brunzell, JD
    Motulsky, AC
    [J]. CIRCULATION, 2000, 101 (24) : 2777 - 2782
  • [5] PATIENTS WITH EARLY-ONSET PERIPHERAL VASCULAR-DISEASE HAVE INCREASED LEVELS OF AUTOANTIBODIES AGAINST OXIDIZED LDL
    BERGMARK, C
    WU, R
    DEFAIRE, U
    LEFVERT, AK
    SWEDENBORG, J
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (04) : 441 - 445
  • [6] BOYD HC, 1989, AM J PATHOL, V135, P815
  • [7] Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis
    Bui, MN
    Sack, MN
    Moutsatsos, G
    Lu, DY
    Katz, P
    McCown, R
    Breall, JA
    Rackley, CE
    [J]. AMERICAN HEART JOURNAL, 1996, 131 (04) : 663 - 667
  • [8] Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis
    Camejo, G
    Hurt-Camejo, E
    Wiklund, O
    Bondjers, G
    [J]. ATHEROSCLEROSIS, 1998, 139 (02) : 205 - 222
  • [9] CAMEJO G, 1991, J LIPID RES, V32, P1983
  • [10] CAMPOS E, 1992, J LIPID RES, V33, P369